secwatch / observer
8-K filed March 27, 2026, 7:59 PM ET ticker ITRMF CIK 0001659323
other material confidence high sentiment negative materiality 1.00

Iterum Therapeutics plc (ITRMF): debt financing — Iterum Therapeutics files for winding up in Ireland; appoints provisional liquidators; CEO/CFO resign

Iterum Therapeutics plc

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Iterum Therapeutics plc reported a default on senior notes at prime rate of interest quoted by Bloomberg on such date or on the most recent da.

Instrument
senior notes
Rate
prime rate of interest quoted by Bloomberg on such date or on the most recent da
Event
default
Exact text from the filing
The filing of the Winding Up Petition described in Item 1.03 above constitutes an event of default under the Company’s Limited Recourse Royalty-Linked Subordinated Notes, dated as of January 21, 2020 (the “Royalty-Linked Notes”), issued pursuant to an Indenture between Iterum Therapeutics Bermuda Limited, as the note issuer, the Company, Iterum Therapeutics International Limited, Iterum Therapeutics US Limited and Iterum Therapeutics US Holding Limited, as guarantors, Iterum Holders’ Representative LLC, as holders’ representative, and Computershare Trust Company, N.A., as trustee.
View on SEC.gov

73 debt financings filed in the last 30 days. Browse all debt financings →

Iterum Therapeutics plc filing history →

Source: SEC EDGAR
accession 0001193125-26-127785
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.